Lewy Body Dementia clinical trials at UCSD
3 in progress, 0 open to eligible people
RewinD-LB - Clinical Study of Neflamapimod in Patients with Dementia with Lewy Bodies
Sorry, in progress, not accepting new patients
The purpose of this study is to determine whether neflamapimod can improve learning skills, problem solving skills, and memory loss in people diagnosed with DLB. More specifically, improvement in verbal learning, memory, and attention, as well as cognitive and functional performance will be measured.
La Jolla, California and other locations
Diagnostic Test for Dementia With Lewy Bodies
Sorry, in progress, not accepting new patients
The Syn-D Study will be evaluating α-synuclein in patients with suspected MCI-AD and MCI-DLB. Using a simple diagnostic test will improve clinical accuracy in diagnosing, earlier diagnosis, and distinguish between neurodegenerative diseases.
La Jolla, California and other locations
Environmental and Reproductive Health Risk for Lewy Body Dementia
Sorry, in progress, not accepting new patients
The goal of this survey study is to identify environmental, occupational and reproductive health risk factors for Lewy body dementia, which includes Parkinson's disease dementia and dementia with Lewy bodies. Participants will complete a one-time survey online or over the phone that includes questions on environmental, occupational factors they may have been exposed to and on medical history including reproductive health. Researchers will then compare the responses of people with Lewy body dementia and people without Parkinson's or memory/thinking problems to see which factors play a role in Lewy body dementia. Identifying risk factors can guide future treatment efforts and provide more insight to this dementia.
La Jolla, California
Last updated: